Altamira Therapeutics Ltd... (CYTO)
0.30
0.00 (0.00%)
At close: Dec 19, 2024, 9:00 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
| PE Ratio | -0.2 | -0.15 | -1.26 | -1.7 | -1.37 | -1.24 | -2.16 | -2.44 | -10.63 | -11.8 | -12.86 | -43.09 | n/a |
| PS Ratio | n/a | 13.36 | 343.11 | 79.98 | -162.77 | 11.27 | 164.01 | -180.57 | -4.71K | 71.34 | n/a | n/a | n/a |
| PB Ratio | 0.22 | -0.49 | 1.73 | 0.83 | 1.51 | 3.91 | -24.43 | 5.29 | 7.06 | 4.03 | 21.35 | -812.74 | n/a |
| P/FCF Ratio | -0.12 | -0.38 | -1.29 | -1.95 | -0.8 | -0.94 | -2.16 | -2.52 | -10.96 | -10.44 | -13.63 | -42.84 | n/a |
| P/OCF Ratio | -0.12 | -0.47 | -1.6 | -2.88 | -1.09 | -1.08 | -2.18 | -2.54 | -10.99 | -11.11 | -13.73 | -44.09 | n/a |
| OCF/S Ratio | n/a | -28.41 | -214.03 | -27.76 | 149.88 | -10.45 | -75.39 | 71.14 | 428.76 | -6.42 | n/a | n/a | n/a |
| Debt / Equity Ratio | n/a | -0.71 | n/a | 0.03 | n/a | 0.39 | -4.68 | 0.87 | n/a | n/a | 1.52 | n/a | n/a |
| Quick Ratio | 1.38 | 0.14 | 0.60 | 122.05 | 434.96 | 1.35 | 1.53 | 3.76 | 8.36 | 12.96 | 1.45 | 0.22 | 1.41 |
| Current Ratio | 1.38 | 0.14 | 0.77 | 3.83 | 1.04 | 1.33 | 1.52 | 3.76 | 8.28 | 13.01 | 1.48 | 0.44 | 1.41 |
| Asset Turnover | n/a | 0.05 | 0.00 | 0.01 | -0.01 | 0.13 | 0.02 | -0.01 | -0.00 | 0.05 | n/a | n/a | n/a |
| Interest Coverage | n/a | -28.66 | -90.14 | -39.09 | -253.57 | -10.24 | -14.85 | -36.48 | -3.86K | -447.14 | -291.29 | n/a | n/a |
| Return on Equity (ROE) | -1.13 | 3.19 | -1.37 | -0.49 | -1.1 | -3.15 | 11.29 | -2.17 | -0.66 | -0.34 | -1.66 | 18.86 | n/a |
| Return on Assets (ROA) | -0.94 | -4.21 | -0.92 | -0.39 | -0.72 | -1.16 | -1.37 | -0.86 | -0.56 | -0.31 | -0.57 | -5.32 | n/a |
| Return on Capital (ROIC) | -0.87 | 3.97 | -1.22 | -0.3 | -1.04 | -2.06 | -3.29 | -1.13 | -0.66 | -0.4 | -1.51 | 3.32K | n/a |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | n/a | -3.72% | -34.07% | 1.00% | 1.00% | 1.00% | 1.00% | 1.00% | 1.00% | 1.00% | n/a | n/a | n/a |
| Net Profit Margin | n/a | -86.8% | -272.22% | -47% | 118.43% | -9.08% | -75.81% | 74.06% | 443.36% | -6.04% | n/a | n/a | n/a |
| Pretax Profit Margin | n/a | -86.84% | -271.88% | -47.12% | 121.89% | -8.95% | -75.86% | 74.38% | 443.36% | -6.04% | n/a | n/a | n/a |
| Operating Profit Margin | n/a | -85.51% | -267.68% | -30.28% | 129.63% | -8.65% | -75.66% | 73.00% | 460.87% | -7.38% | n/a | n/a | n/a |
| FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |